Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,460,188
+$1,555,259 QoQ
Shares Held
45,542
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#856
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDGEWOOD MANAGEMENT LLC holds $489,984,447 across 7 Drug Manufacturers - General names. ABBV ranks #2 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
388,627 | $466,130,921 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
45,542 | $11,460,188 | |
| 3 | JNJ |
Johnson & Johnson
|
18,371 | $4,665,682 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
27,837 | $3,516,926 | |
| 5 | PFE |
Pfizer Inc
|
82,179 | $1,978,870 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,522 | $1,240,097 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,718 | $991,763 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,460,188 | 45,542 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,904,929 | 45,542 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,890,034 | 56,414 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,145,957 | 65,414 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,038,505 | 70,243 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,717,313 | 70,243 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,548,381 | 76,243 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,056,467 | 76,243 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,783,175 | 80,359 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,664,513 | 80,530 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,479,734 | 80,530 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,003,801 | 80,530 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,876,752 | 80,730 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,865,940 | 80,730 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,046,775 | 80,730 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,834,773 | 80,730 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,364,606 | 80,730 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,087,140 | 80,730 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $10,930,842 | 80,730 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,708,345 | 80,730 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,065,267 | 80,480 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,709,545 | 80,480 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,623,432 | 80,480 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,049,243 | 80,480 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,813,164 | 79,580 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $6,063,200 | 79,580 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||